Correlation Between Relay Therapeutics and PTC Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and PTC Therapeutics, you can compare the effects of market volatilities on Relay Therapeutics and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and PTC Therapeutics.

Diversification Opportunities for Relay Therapeutics and PTC Therapeutics

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Relay and PTC is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and PTC Therapeutics go up and down completely randomly.

Pair Corralation between Relay Therapeutics and PTC Therapeutics

Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the PTC Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Relay Therapeutics is 1.09 times less risky than PTC Therapeutics. The stock trades about -0.27 of its potential returns per unit of risk. The PTC Therapeutics is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  3,992  in PTC Therapeutics on September 1, 2024 and sell it today you would earn a total of  396.00  from holding PTC Therapeutics or generate 9.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Relay Therapeutics  vs.  PTC Therapeutics

 Performance 
       Timeline  
Relay Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relay Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
PTC Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Relay Therapeutics and PTC Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Relay Therapeutics and PTC Therapeutics

The main advantage of trading using opposite Relay Therapeutics and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.
The idea behind Relay Therapeutics and PTC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Valuation
Check real value of public entities based on technical and fundamental data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios